Literature DB >> 28819872

[Hearing restoration with cochlear implants after translabyrinthine vestibular schwannoma resection].

C Bohr1, S Müller2, J Hornung2, U Hoppe2, H Iro2.   

Abstract

BACKGROUND: Hearing restoration after translabyrinthine vestibular schwannoma resection is a challenge. Because the cochlea can begin to ossify a few months after cochlear or labyrinthine injury, the time interval for cochlear implant surgery is limited. To avoid complete ossification and to prolong the time interval until cochlear implantation, it is possible to insert a placeholder (depth gauge) into the cochlea and perform the cochlear implant surgery at a later time point (two-stage approach).
OBJECTIVE: The aim of this retrospective case series was to present the outcomes after restoration of hearing with cochlea implants in six patients and to evaluate the use of the depth gauge in practice.
METHODS: The hearing outcome of all patients with (n = 3) and without (n = 3) insertion of a depth gauge was measured with the Freiburg monosyllabic test without background noise at 65 dB. The first measurement was performed prior to the translabyrinthine vestibular schwannoma resection, the last measurement was performed up to 48 months after cochlear implantation.
RESULTS: All 6 patients reached 22.5 ± 36.57% prior to vestibular schwannoma resection and 41.3 ± 26% 12 months after cochlear implantation. The understanding values of the patients with a depth gauge were 25.8 ± 16% after 12 months which is below the values of the other patients with 56.6 ± 25.0%. No severe intraoperative or postoperative complications occurred in any patient.
CONCLUSION: The two-stage approach for cochlear implantation with depth gauge insertion following labrynthine incision and intact nerve appears to represent a very promising and safe variation for hearing restoration. Intensified research on this approach seems to be justified and necessary.

Entities:  

Keywords:  Ear, inner; Hearing; Intraoperative complications; Neuroma, acoustic; Postoperative complications

Mesh:

Year:  2017        PMID: 28819872     DOI: 10.1007/s00106-017-0404-2

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  18 in total

1.  Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.

Authors:  Matthew L Carlson; Joseph T Breen; Colin L Driscoll; Michael J Link; Brian A Neff; René H Gifford; Charles W Beatty
Journal:  Otol Neurotol       Date:  2012-07       Impact factor: 2.311

2.  Is cochlear implantation possible after acoustic tumor removal?

Authors:  A Belal
Journal:  Otol Neurotol       Date:  2001-07       Impact factor: 2.311

3.  Pediatric cochlear implant revision surgery and reimplantation: an analysis of 957 cases.

Authors:  Yüksel Olgun; Asuman Feda Bayrak; Tolgahan Catli; Mehmet Emrah Ceylan; Ruhi Aydin; Ufuk Duzenli; Levent Olgun
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-07-21       Impact factor: 1.675

4.  Cochlear obliteration after translabyrinthine vestibular schwannoma surgery.

Authors:  Caroline Beutner; Christian Mathys; Bernd Turowski; Jörg Schipper; Thomas Klenzner
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-11       Impact factor: 2.503

5.  Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.

Authors:  Simon Kingsley Wickham Lloyd; Fergal John Glynn; Scott Alexander Rutherford; Andrew Thomas King; Deborah Jane Mawman; Martin Paul O'Driscoll; Dafydd Gareth Richard Evans; Richard Thomas Ramsden; Simon Richard Mackenzie Freeman
Journal:  Otol Neurotol       Date:  2014-01       Impact factor: 2.311

6.  Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: report of two cases (neurofibromatosis type 2 and unilateral vestibular schwannoma).

Authors:  Miguel Arístegui; Antonio Denia
Journal:  Otol Neurotol       Date:  2005-03       Impact factor: 2.311

7.  Clinical outcome after cochlear implantation in patients with unilateral hearing loss due to labyrinthitis ossificans.

Authors:  Frederike Hassepass; Christian Schild; Antje Aschendorff; Roland Laszig; Wolfgang Maier; Rainer Beck; Thomas Wesarg; Susan Arndt
Journal:  Otol Neurotol       Date:  2013-09       Impact factor: 2.311

8.  Cochlear implants to treat deafness caused by vestibular schwannomas.

Authors:  Payal Mukherjee; James D Ramsden; Nick Donnelly; Patrick Axon; Shakeel Saeed; Paul Fagan; Richard M Irving
Journal:  Otol Neurotol       Date:  2013-09       Impact factor: 2.311

9.  [Cochlear implant treatment of patients with single-sided deafness or asymmetric hearing loss. German version].

Authors:  S Arndt; R Laszig; A Aschendorff; F Hassepass; R Beck; T Wesarg
Journal:  HNO       Date:  2017-07       Impact factor: 1.284

10.  Simultaneous translabyrinthine removal of acoustic neuroma and cochlear implantation.

Authors:  Diego Zanetti; Chiara Barbara Campovecchi; Sara Pasini; Nader Nassif
Journal:  Auris Nasus Larynx       Date:  2008-02-19       Impact factor: 1.863

View more
  6 in total

Review 1.  Neuromonitoring of the cochlear nerve during vestibular schwannoma resection and simultaneous cochlear implantation.

Authors:  Nora M Weiss; Wilma Großmann; Sebastian P Schraven; Tobias Oberhoffner; Robert Mlynski
Journal:  HNO       Date:  2021-05-21       Impact factor: 1.284

Review 2.  [Neuromonitoring of the cochlear nerve during vestibular schwannoma resection and simultaneous cochlear implantation. German version].

Authors:  Nora M Weiss; Wilma Großmann; Sebastian Schraven; Tobias Oberhoffner; Robert Mlynski
Journal:  HNO       Date:  2021-03-17       Impact factor: 1.284

3.  Cochlear Implantation in Sporadic Vestibular Schwannoma: A Systematic Literature Review.

Authors:  Matthew Robert Bartindale; Kent Sean Tadokoro; Matthew Lowell Kircher
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-08

4.  [Hearing classification in patients with vestibular schwannoma using German-language test procedures].

Authors:  T Rahne; S K Plontke; D Vordermark; C Strauss; C Scheller
Journal:  HNO       Date:  2020-09-25       Impact factor: 1.284

5.  Considerations for Continuing Semielective and Emergency Otolaryngological Procedures During the COVID-19 Pandemic.

Authors:  Sarina K Mueller; Maximilian Traxdorf; Konstantinos Mantsopoulos; Antoniu-Oreste Gostian; Matti Sievert; Michael Koch; Matthias J Huebner; Heinrich Iro
Journal:  Ear Nose Throat J       Date:  2020-09-07       Impact factor: 1.697

6.  Management of transmodiolar and transmacular cochleovestibular schwannomas with and without cochlear implantation.

Authors:  S K Plontke; P Caye-Thomasen; C Strauss; S Kösling; G Götze; U Siebolts; D Vordermark; L Wagner; L Fröhlich; T Rahne
Journal:  HNO       Date:  2021-01       Impact factor: 1.284

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.